I think vaccine resistance imposes a ceiling, but the expense and sheer difficulty of distributing mRNA vaccines in cold storage is also a major problem (it’s why Covax refused donations for a bit), so a room temperature shelf stable vaccine is likely to be quite valuable.
I think vaccine resistance imposes a ceiling, but the expense and sheer difficulty of distributing mRNA vaccines in cold storage is also a major problem (it’s why Covax refused donations for a bit), so a room temperature shelf stable vaccine is likely to be quite valuable.